$2.51 Billion is the total value of Third Security, LLC's 23 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 5.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XON | INTREXON CORP | $1,962,845,000 | -34.8% | 61,724,682 | 0.0% | 78.09% | -0.8% | |
| HALO | HALOZYME THERAPEUTICS INC | $266,308,000 | -40.5% | 19,829,337 | 0.0% | 10.60% | -9.5% | |
| ZIOP | ZIOPHARM ONCOLOGY INC | $87,088,000 | -24.9% | 9,665,742 | 0.0% | 3.46% | +14.3% | |
| FCSC | Buy | FIBROCELL SCIENCE INC | $63,989,000 | -22.4% | 16,620,414 | +6.2% | 2.55% | +18.1% |
| SYN | Buy | SYNTHETIC BIOLOGICS INC | $30,051,000 | -14.3% | 13,238,268 | +7.6% | 1.20% | +30.4% |
| EPD | ENTERPRISE PRODS PARTNERS L | $25,792,000 | -16.7% | 1,035,834 | 0.0% | 1.03% | +26.8% | |
| OGEN | ORAGENICS INC | $16,136,000 | +19.7% | 9,839,221 | 0.0% | 0.64% | +82.4% | |
| ET | Buy | ENERGY TRANSFER EQUITY L P | $15,657,000 | -35.1% | 752,400 | +100.0% | 0.62% | -1.3% |
| HSGX | HISTOGENICS CORP | $10,708,000 | -38.4% | 2,690,570 | 0.0% | 0.43% | -6.2% | |
| GEL | GENESIS ENERGY L Punit ltd partn | $8,320,000 | -12.6% | 217,000 | 0.0% | 0.33% | +32.9% | |
| NS | NUSTAR ENERGY LP | $5,222,000 | -24.5% | 116,500 | 0.0% | 0.21% | +14.9% | |
| TCP | TC PIPELINES LP | $4,618,000 | -16.5% | 97,000 | 0.0% | 0.18% | +26.9% | |
| APHB | New | AMPLIPHI BIOSCIENCES CORP | $4,577,000 | – | 1,158,788 | +100.0% | 0.18% | – |
| MMLP | MARTIN MIDSTREAM PRTNRS L Punit l p int | $3,460,000 | -21.2% | 141,800 | 0.0% | 0.14% | +20.0% | |
| ETP | Buy | ENERGY TRANSFER PRTNRS L Punit ltd partn | $3,188,000 | -21.3% | 77,635 | +0.0% | 0.13% | +19.8% |
| OVAS | OVASCIENCE INC | $3,169,000 | -70.6% | 373,224 | 0.0% | 0.13% | -55.3% | |
| CMLP | CRESTWOOD MIDSTREAM PARTNERSunit ltd partner | $1,759,000 | -44.8% | 284,620 | 0.0% | 0.07% | -15.7% | |
| TBIO | TRANSGENOMIC INC | $709,000 | -44.9% | 770,490 | 0.0% | 0.03% | -17.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-10-20
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HALOZYME THERAPEUTICS INC | 36 | Q1 2022 | 37.6% |
| TC PIPELINES LP | 30 | Q3 2020 | 1.1% |
| ENTERPRISE PRODS PARTNERS L | 29 | Q2 2020 | 6.7% |
| ENERGY TRANSFER LP | 29 | Q2 2020 | 2.7% |
| NUSTAR ENERGY LP | 29 | Q2 2020 | 1.3% |
| INTREXON CORP | 26 | Q4 2019 | 82.5% |
| ZIOPHARM ONCOLOGY INC | 25 | Q2 2020 | 7.5% |
| AQUABOUNTY TECHNOLOGIES INC | 23 | Q3 2022 | 16.9% |
| SYNTHETIC BIOLOGICS INC | 21 | Q2 2018 | 4.0% |
| ORAGENICS INC | 19 | Q4 2017 | 3.9% |
View Third Security, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Third Security, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.